Jessica Foley
Nurse Practitioner · Overland Park, KSNPI 1144593328
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.8% of the total across 292 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 292 payments — averaging $18.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$1K
- AstraZeneca$1K
- Regeneron Healthcare Solutions, Inc.$796
- Takeda Pharmaceuticals U.S.A., Inc.$502
- GSK$373
- AbbVie$132
- plus $1K from 20 others
What the payments were for
- Consulting fees$180%
- Food & beverage$5,19796%
- Education$2074%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 68 | $1,265 |
| AstraZeneca | 52 | $1,174 |
| Regeneron Healthcare Solutions, Inc. | 57 | $796 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $502 |
| GSK | 20 | $373 |
| AbbVie | 6 | $132 |
| Hikma Pharmaceuticals USA | 11 | $132 |
| Novartis | 7 | $131 |
| Amgen | 5 | $104 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $102 |
| Hospira, Inc. | 6 | $100 |
| Genentech USA, Inc. | 6 | $98 |
| Kaleo, Inc. | 5 | $94 |
| Grifols USA, LLC | 3 | $69 |
| CSL Behring | 2 | $60 |
| Pfizer | 3 | $58 |
| Pharming Healthcare, Inc. | 2 | $48 |
| Azurity Pharmaceuticals, Inc. | 1 | $28 |
| Merck | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
| Boehringer Ingelheim | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
| ADMA Biomanufacturing LLC | 1 | $18 |
| Galderma Laboratories, L.p. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$241
How this compares
$5,422 in reported general payments places this provider in the 95th percentile of 1,326 nurse practitioner providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 38 | $30,602 |
| Advair HfaFluticasone Propion/Salmeterol | 17 | $8,453 |
| Breo ElliptaFluticasone/Vilanterol | 20 | $8,428 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 54 | $7,621 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $7,384 |
| DuleraMometasone/Formoterol | 17 | $5,629 |
| Azelastine Hcl | 95 | $4,950 |
| Arnuity ElliptaFluticasone Furoate | 22 | $4,923 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $4,719 |
| BreynaBudesonide/Formoterol Fumarate | 16 | $2,480 |
| Fluticasone Propionate | 75 | $1,423 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 55 | $1,370 |
| Montelukast Sodium | 136 | $1,338 |
| Ipratropium Bromide | 29 | $876 |
| Famotidine | 23 | $398 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $373 | $43,95380 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,174 | $12,10323 claims |
| MerckDulera | $25 | $5,62917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,326 nurse practitioner providers in Kansas.
Other nurse practitioner in Overland Park
- Morteza RabiiOverland Park$88K
- Diane GonzalezOverland Park$18K
- Brenda LaneOverland Park$14K
- Katelyn FreemanOverland Park$10K
- Stephanie LeeOverland Park$9K
- Jennifer KershnerOverland Park$7K
- Kimberly NagelOverland Park$6K
- Valentina AlmarazOverland Park$6K
- Gary GrafTopeka$726K
- Anna ShortRoeland Park$215K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.